Skip to content

Metabolism in Psychiatry 3 - Predicting weight gain and therapy response in unipolar depression

Metabolism in Psychiatry 3 - Predicting weight gain and therapy response in unipolar depression - MiP3D

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025946
Enrollment
171
Registered
2021-08-17
Start date
2021-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: The course of body weight and symptoms will be observed over four weeks after the start of medicinal antidepressant treatment in a group of patients with secured diagnosis of depression.

Sponsors

Klinikum der Universität München, Campus Großhadern
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: - diagnosis of a current depressive episode (ICD-10: F32.x) or recurrent depression (ICD-10: F33.x) - male and female psychiatric inpatients aged between 18 and 70 years - ability to sufficiently speak and comprehend the German language - continuing or beginning antidepressant drug regimen within two weeks after admission - MADRS score = 14 - capability of providing written informed consent or in agreement with a legal representative.

Exclusion criteria

Exclusion criteria: - cognitive disability impeding completion of self-rating questionnaires or answering questions reasonably; - presence of psychotic features, manic episode, bipolar disorder, disorders from the schizophreniform spectrum, eating disorder, drug or alcohol addiction. Other disorders (e.g. adjustment disorder, obsessive compulsive disorder, anxiety disorder, somatoform disorder, personality disorder) in case the symptoms predominate the clinical picture; - presence of uncontrolled systemic disease, uncontrolled somatic (other than metabolic or cardiovascular disturbances) / neurological disorder (apart from migraine), current or recent (last month) severe infections or inflammatory disease, current or recent (last month) physical trauma; - treatment with ECT; - patients with immediate risk for suicidal behavior; - pregnant, breast-feeding, or postmenopausal women.

Design outcomes

Primary

MeasureTime frame
body weight change after 4 weeks (neasurement of body weight), symptom score change after 4 weeks (MADRS score)

Secondary

MeasureTime frame
Correlations of relevant biomarkers and patient characteristics

Countries

Germany

Contacts

Public ContactMaria Simon

Klinik für Psychiatrie und Psychotherapie, Klinikum der Universität München, Ludwig-Maximilians-Universität München

Maria.Simonqmed.uni-muenchen.de004989440052769

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026